Works by Shimokawa, Mototsugu


Results: 205
    1

    Docetaxel Plus RAmucirumab With Primary Prophylactic Pegylated Granulocyte-ColONy Stimulating Factor Support for Elderly Patients With Advanced Non-small-cell Lung Cancer: A Multicenter Prospective Single Arm Phase II Trial: DRAGON Study (WJOG9416L).

    Published in:
    2018
    By:
    • Akito Hata;
    • Nobuyuki Katakami;
    • Mototsugu Shimokawa;
    • Tetsuya Mitsudomi;
    • Nobuyuki Yamamoto;
    • Kazuhiko Nakagawa;
    • Hata, Akito;
    • Katakami, Nobuyuki;
    • Shimokawa, Mototsugu;
    • Mitsudomi, Tetsuya;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    journal article
    2
    3

    A Comprehensive Analysis of Programmed Cell Death Ligand-1 Expression With the Clone SP142 Antibody in Non-Small-Cell Lung Cancer Patients.

    Published in:
    2017
    By:
    • Kazuki Takada;
    • Gouji Toyokawa;
    • Tatsuro Okamoto;
    • Mototsugu Shimokawa;
    • Yuka Kozuma;
    • Taichi Matsubara;
    • Naoki Haratake;
    • Takaki Akamine;
    • Shinkichi Takamori;
    • Masakazu Katsura;
    • Fumihiro Shoji;
    • Yoshinao Oda;
    • Yoshihiko Maehara;
    • Takada, Kazuki;
    • Toyokawa, Gouji;
    • Okamoto, Tatsuro;
    • Shimokawa, Mototsugu;
    • Kozuma, Yuka;
    • Matsubara, Taichi;
    • Haratake, Naoki
    Publication type:
    journal article
    4

    Relationship between hyperemesis gravidarum and small-for-gestational-age in the Japanese population: the Japan Environment and Children's Study (JECS).

    Published in:
    2016
    By:
    • Seiichi Morokuma;
    • Mototsugu Shimokawa;
    • Kiyoko Kato;
    • Masafumi Sanefuji;
    • Eiji Shibata;
    • Mayumi Tsuji;
    • Ayako Senju;
    • Toshihiro Kawamoto;
    • Koichi Kusuhara;
    • Morokuma, Seiichi;
    • Shimokawa, Mototsugu;
    • Kato, Kiyoko;
    • Sanefuji, Masafumi;
    • Shibata, Eiji;
    • Tsuji, Mayumi;
    • Senju, Ayako;
    • Kawamoto, Toshihiro;
    • Kusuhara, Koichi;
    • Japan Environment & Children’s Study Group
    Publication type:
    journal article
    5
    6
    7

    Is Sublobar Resection Feasible for High-Risk Pathologic Stage I Non-small Cell Lung Cancer?

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2025, v. 32, n. 6, p. 4161, doi. 10.1245/s10434-024-16700-z
    By:
    • Akamine, Takaki;
    • Wakasu, Sho;
    • Matsubara, Taichi;
    • Yamaguchi, Masafumi;
    • Yamazaki, Koji;
    • Hamatake, Motoharu;
    • Kometani, Takuro;
    • Kinoshita, Fumihiko;
    • Kohno, Mikihiro;
    • Shimokawa, Mototsugu;
    • Takenaka, Tomoyoshi;
    • Yoshizumi, Tomoharu
    Publication type:
    Article
    8
    9

    Comparison of laparoscopic surgery with open standard surgery for advanced gastric carcinoma in a single institute: a propensity score matching analysis.

    Published in:
    Surgical Endoscopy & Other Interventional Techniques, 2022, v. 36, n. 5, p. 3356, doi. 10.1007/s00464-021-08652-2
    By:
    • Yamamoto, Manabu;
    • Shimokawa, Mototsugu;
    • Ohta, Mitsuhiko;
    • Uehara, Hideo;
    • Sugiyama, Masahiko;
    • Nakashima, Yuichiro;
    • Nakanoko, Tomonori;
    • Ikebe, Masahiko;
    • Shin, Yuki;
    • Shiokawa, Keiichi;
    • Morita, Masaru;
    • Toh, Yasushi
    Publication type:
    Article
    10
    11
    12

    Author Correction: C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel.

    Published in:
    2024
    By:
    • Shirakawa, Tsuyoshi;
    • Makiyama, Akitaka;
    • Shimokawa, Mototsugu;
    • Otsuka, Taiga;
    • Shinohara, Yudai;
    • Koga, Futa;
    • Ueda, Yujiro;
    • Nakazawa, Junichi;
    • Otsu, Satoshi;
    • Komori, Azusa;
    • Arima, Shiho;
    • Fukahori, Masaru;
    • Taguchi, Hiroki;
    • Honda, Takuya;
    • Shibuki, Taro;
    • Nio, Kenta;
    • Ide, Yasushi;
    • Ureshino, Norio;
    • Mizuta, Toshihiko;
    • Mitsugi, Kenji
    Publication type:
    Correction Notice
    13

    Efficacy of second-line chemotherapy after treatment with gemcitabine plus nab-paclitaxel or FOLFIRINOX in patients with metastatic pancreatic cancer.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-46924-0
    By:
    • Fukahori, Masaru;
    • Okabe, Yoshinobu;
    • Shimokawa, Mototsugu;
    • Otsuka, Taiga;
    • Koga, Futa;
    • Ueda, Yujiro;
    • Nakazawa, Junichi;
    • Komori, Azusa;
    • Otsu, Satoshi;
    • Arima, Shiho;
    • Makiyama, Akitaka;
    • Taguchi, Hiroki;
    • Honda, Takuya;
    • Ushijima, Tomoyuki;
    • Miwa, Keisuke;
    • Shibuki, Taro;
    • Nio, Kenta;
    • Ide, Yasushi;
    • Ureshino, Norio;
    • Mizuta, Toshihiko
    Publication type:
    Article
    14

    C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-34962-7
    By:
    • Shirakawa, Tsuyoshi;
    • Makiyama, Akitaka;
    • Shimokawa, Mototsugu;
    • Otsuka, Taiga;
    • Shinohara, Yudai;
    • Koga, Futa;
    • Ueda, Yujiro;
    • Nakazawa, Junichi;
    • Otsu, Satoshi;
    • Komori, Azusa;
    • Arima, Shiho;
    • Fukahori, Masaru;
    • Taguchi, Hiroki;
    • Honda, Takuya;
    • Shibuki, Taro;
    • Nio, Kenta;
    • Ide, Yasushi;
    • Ureshino, Norio;
    • Mizuta, Toshihiko;
    • Mitsugi, Kenji
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Predicting osimertinib‐treatment outcomes through EGFR mutant‐fraction monitoring in the circulating tumor DNA of EGFR T790M‐positive patients with non‐small cell lung cancer (WJOG8815L).

    Published in:
    Molecular Oncology, 2021, v. 15, n. 1, p. 126, doi. 10.1002/1878-0261.12841
    By:
    • Sakai, Kazuko;
    • Takahama, Takayuki;
    • Shimokawa, Mototsugu;
    • Azuma, Koichi;
    • Takeda, Masayuki;
    • Kato, Terufumi;
    • Daga, Haruko;
    • Okamoto, Isamu;
    • Akamatsu, Hiroaki;
    • Teraoka, Shunsuke;
    • Ono, Akira;
    • Ohira, Tatsuo;
    • Yokoyama, Toshihide;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko;
    • Nishio, Kazuto
    Publication type:
    Article
    24
    25

    Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study).

    Published in:
    British Journal of Cancer, 2023, v. 129, n. 6, p. 1032, doi. 10.1038/s41416-023-02378-9
    By:
    • Ando, Koji;
    • Nakamura, Yoshiaki;
    • Kitao, Hiroyuki;
    • Shimokawa, Mototsugu;
    • Kotani, Daisuke;
    • Bando, Hideaki;
    • Nishina, Tomohiro;
    • Yamada, Takanobu;
    • Yuki, Satoshi;
    • Narita, Yukiya;
    • Hara, Hiroki;
    • Ohta, Takashi;
    • Esaki, Taito;
    • Hamamoto, Yasuo;
    • Kato, Ken;
    • Yamamoto, Yoshiyuki;
    • Minashi, Keiko;
    • Ohtsubo, Koushiro;
    • Izawa, Naoki;
    • Kawakami, Hisato
    Publication type:
    Article
    26
    27

    A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study.

    Published in:
    BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-09385-8
    By:
    • Takada, Kazuki;
    • Shimokawa, Mototsugu;
    • Takamori, Shinkichi;
    • Shimamatsu, Shinichiro;
    • Hirai, Fumihiko;
    • Tagawa, Tetsuzo;
    • Okamoto, Tatsuro;
    • Hamatake, Motoharu;
    • Tsuchiya-Kawano, Yuko;
    • Otsubo, Kohei;
    • Inoue, Koji;
    • Yoneshima, Yasuto;
    • Tanaka, Kentaro;
    • Okamoto, Isamu;
    • Nakanishi, Yoichi;
    • Mori, Masaki
    Publication type:
    Article
    28

    Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: A post-hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study).

    Published in:
    2022
    By:
    • Shibuki, Taro;
    • Mizuta, Toshihiko;
    • Shimokawa, Mototsugu;
    • Koga, Futa;
    • Ueda, Yujiro;
    • Nakazawa, Junichi;
    • Komori, Azusa;
    • Otsu, Satoshi;
    • Arima, Shiho;
    • Fukahori, Masaru;
    • Makiyama, Akitaka;
    • Taguchi, Hiroki;
    • Honda, Takuya;
    • Mitsugi, Kenji;
    • Nio, Kenta;
    • Ide, Yasushi;
    • Ureshino, Norio;
    • Shirakawa, Tsuyoshi;
    • Otsuka, Taiga
    Publication type:
    journal article
    29
    30
    31
    32
    33

    Perioperative Allogeneic Blood Transfusion Does not Influence Patient Survival After Hepatectomy for Hepatocellular Carcinoma: A Propensity Score Matching Analysis.

    Published in:
    World Journal of Surgery, 2019, v. 43, n. 11, p. 2894, doi. 10.1007/s00268-019-05085-w
    By:
    • Yamashita, Yo-ichi;
    • Hayashi, Hiromitsu;
    • Imai, Katsunori;
    • Okabe, Hirohisa;
    • Nakagawa, Shigeki;
    • Kitamura, Fumimasa;
    • Uemura, Norio;
    • Nakao, Yosuke;
    • Yusa, Toshihiko;
    • Itoyama, Rumi;
    • Yamao, Takanobu;
    • Umesaki, Naoki;
    • Miyata, Tatsunori;
    • Chikamoto, Akira;
    • Shimokawa, Mototsugu;
    • Baba, Hideo
    Publication type:
    Article
    34
    35
    36

    A phase two trial evaluating FOLFIRI plus aflibercept after failure of FOLFOXIRI plus bevacizumab in patients with unresectable metastatic colorectal cancer.

    Published in:
    International Journal of Clinical Oncology, 2025, v. 30, n. 3, p. 514, doi. 10.1007/s10147-025-02701-9
    By:
    • Ando, Koji;
    • Satake, Hironaga;
    • Shimokawa, Mototsugu;
    • Yasui, Hisateru;
    • Negoro, Yuji;
    • Kinjo, Tatsuya;
    • Kizaki, Junya;
    • Baba, Kenji;
    • Orita, Hiroyuki;
    • Hirata, Keiji;
    • Sakamoto, Sanae;
    • Makiyama, Akitaka;
    • Saeki, Hiroshi;
    • Tsuji, Akihito;
    • Baba, Hideo;
    • Oki, Eiji
    Publication type:
    Article
    37
    38

    New predictors of microvascular invasion for small hepatocellular carcinoma ≤ 3 cm.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1182, doi. 10.1007/s10147-024-02553-9
    By:
    • Fukushima, Ryosuke;
    • Harimoto, Norifumi;
    • Okuyama, Takayuki;
    • Seki, Takaomi;
    • Hoshino, Kouki;
    • Hagiwara, Kei;
    • Kawai, Shunsuke;
    • Ishii, Norihiro;
    • Tsukagoshi, Mariko;
    • Igarashi, Takamichi;
    • Araki, Kenichiro;
    • Tomonaga, Hiroyasu;
    • Higuchi, Tetsuya;
    • Shimokawa, Mototsugu;
    • Shirabe, Ken
    Publication type:
    Article
    39

    Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1142, doi. 10.1007/s10147-024-02543-x
    By:
    • Nosaki, Kaname;
    • Yoh, Kiyotaka;
    • Toyozawa, Ryo;
    • Horinouchi, Hidehito;
    • Morise, Masahiro;
    • Ohashi, Kadoaki;
    • Murakami, Haruyasu;
    • Satouchi, Miyako;
    • Sakakibara-Konishi, Jun;
    • Yano, Seiji;
    • Okumura, Fumihiko;
    • Matsumoto, Shingo;
    • Shimokawa, Mototsugu;
    • Seto, Takashi;
    • Goto, Koichi
    Publication type:
    Article
    40

    Effect of duration of adjuvant chemotherapy with S-1 (6 versus 12 months) for resected pancreatic cancer: the multicenter clinical randomized phase II postoperative adjuvant chemotherapy S-1 (PACS-1) trial.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 11, p. 1520, doi. 10.1007/s10147-023-02399-7
    By:
    • Kayashima, Hiroto;
    • Itoh, Shinji;
    • Shimokawa, Mototsugu;
    • Hayashi, Hiromitsu;
    • Takamori, Hiroshi;
    • Fukuzawa, Kengo;
    • Ninomiya, Mizuki;
    • Araki, Kenichiro;
    • Yamashita, Yo-ichi;
    • Sugimachi, Keishi;
    • Uchiyama, Hideaki;
    • Morine, Yuji;
    • Utsunomiya, Tohru;
    • Uwagawa, Tadashi;
    • Maeda, Takashi;
    • Baba, Hideo;
    • Yoshizumi, Tomoharu
    Publication type:
    Article
    41

    Phase II clinical trial to study the safety and efficacy of combined S-1 + oxaliplatin therapy as neoadjuvant chemotherapy for locally advanced gastric cancer in older patients.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1166, doi. 10.1007/s10147-023-02373-3
    By:
    • Ota, Mitsuhiko;
    • Saeki, Hiroshi;
    • Uehara, Hideo;
    • Matsuda, Yoshiko;
    • Tsutsumi, Satoshi;
    • Kusumoto, Tetsuya;
    • Yasui, Hisateru;
    • Ubukata, Yasunari;
    • Yamaguchi, Shohei;
    • Orita, Hiroyuki;
    • Izawa, Naoki;
    • Kakizoe, Saburo;
    • Shimokawa, Mototsugu;
    • Yoshizumi, Tomoharu;
    • Kakeji, Yoshihiro;
    • Mori, Masaki;
    • Oki, Eiji
    Publication type:
    Article
    42

    Scoring model with serum albumin and CA19-9 for metastatic pancreatic cancer in second-line treatment: results from the NAPOLEON study.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 8, p. 1073, doi. 10.1007/s10147-023-02354-6
    By:
    • Komori, Azusa;
    • Otsu, Satoshi;
    • Shimokawa, Mototsugu;
    • Otsuka, Taiga;
    • Koga, Futa;
    • Ueda, Yujiro;
    • Nakazawa, Junichi;
    • Arima, Shiho;
    • Fukahori, Masaru;
    • Okabe, Yoshinobu;
    • Makiyama, Akitaka;
    • Taguchi, Hiroki;
    • Honda, Takuya;
    • Shibuki, Taro;
    • Nio, Kenta;
    • Ide, Yasushi;
    • Ureshino, Norio;
    • Mizuta, Toshihiko;
    • Shirakawa, Tsuyoshi;
    • Mitsugi, Kenji
    Publication type:
    Article
    43

    Real-world clinical outcomes in Japanese patients with locally advanced squamous cell carcinoma of the head and neck treated with radiotherapy plus cetuximab: a prospective observational study (JROSG12-2).

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 11, p. 1675, doi. 10.1007/s10147-022-02228-3
    By:
    • Ota, Yosuke;
    • Kodaira, Takeshi;
    • Fujii, Hirofumi;
    • Shimokawa, Mototsugu;
    • Yokota, Tomoya;
    • Nakashima, Torahiko;
    • Monden, Nobuya;
    • Homma, Akihiro;
    • Ueda, Shinya;
    • Akimoto, Tetsuo
    Publication type:
    Article
    44
    45

    Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB–IIIA non-small cell lung cancer (WJTOG0101).

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 12, p. 2216, doi. 10.1007/s10147-021-02012-9
    By:
    • Yamaguchi, Masafumi;
    • Tada, Hirohito;
    • Mitsudomi, Tetsuya;
    • Seto, Takashi;
    • Yokoi, Kohei;
    • Katakami, Nobuyuki;
    • Nakagawa, Kazuhiko;
    • Oda, Makoto;
    • Ohta, Mitsunori;
    • Sawa, Toshiyuki;
    • Yamashita, Motohiro;
    • Iked, Norihiko;
    • Saka, Hideo;
    • Higashiyama, Masahiko;
    • Nomori, Hiroaki;
    • Semba, Hiroshi;
    • Negoro, Shunichi;
    • Chiba, Yasutaka;
    • Shimokawa, Mototsugu;
    • Fukuoka, Masahiro
    Publication type:
    Article
    46

    Preoperative iron status is a prognosis factor for stage II and III colorectal cancer.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 11, p. 2037, doi. 10.1007/s10147-021-01995-9
    By:
    • Sawayama, Hiroshi;
    • Miyamoto, Yuji;
    • Mima, Kosuke;
    • Kato, Rikako;
    • Ogawa, Katsuhiro;
    • Hiyoshi, Yukiharu;
    • Shimokawa, Mototsugu;
    • Akiyama, Takahiko;
    • Kiyozumi, Yuki;
    • Iwagami, Shiro;
    • Iwatsuki, Masaaki;
    • Baba, Yoshifumi;
    • Yoshida, Naoya;
    • Baba, Hideo
    Publication type:
    Article
    47

    Correction to: A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study.

    Published in:
    2021
    By:
    • Otsuka, Taiga;
    • Shirakawa, Tsuyoshi;
    • Shimokawa, Mototsugu;
    • Koga, Futa;
    • Kawaguchi, Yasunori;
    • Ueda, Yujiro;
    • Nakazawa, Junichi;
    • Komori, Azusa;
    • Otsu, Satoshi;
    • Arima, Shiho;
    • Fukahori, Masaru;
    • Okabe, Yoshinobu;
    • Makiyama, Akitaka;
    • Taguchi, Hiroki;
    • Honda, Takuya;
    • Shibuki, Taro;
    • Nio, Kenta;
    • Ide, Yasushi;
    • Mizuta, Toshihiko;
    • Mitsugi, Kenji
    Publication type:
    Correction Notice
    48

    A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 5, p. 941, doi. 10.1007/s10147-021-01859-2
    By:
    • Otsuka, Taiga;
    • Shirakawa, Tsuyoshi;
    • Shimokawa, Mototsugu;
    • Koga, Futa;
    • Kawaguchi, Yasunori;
    • Ueda, Yujiro;
    • Nakazawa, Junichi;
    • Komori, Azusa;
    • Otsu, Satoshi;
    • Arima, Shiho;
    • Fukahori, Masaru;
    • Okabe, Yoshinobu;
    • Makiyama, Akitaka;
    • Taguchi, Hiroki;
    • Honda, Takuya;
    • Shibuki, Taro;
    • Nio, Kenta;
    • Ide, Yasushi;
    • Mizuta, Toshihiko;
    • Mitsugi, Kenji
    Publication type:
    Article
    49

    Prognostic outcomes and risk factors for recurrence after laser vaporization for cervical intraepithelial neoplasia: a single-center retrospective study.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 4, p. 770, doi. 10.1007/s10147-020-01848-x
    By:
    • Kodama, Keisuke;
    • Yahata, Hideaki;
    • Okugawa, Kaoru;
    • Tomonobe, Hiroshi;
    • Yasutake, Nobuko;
    • Yoshida, Sachiko;
    • Yagi, Hiroshi;
    • Yasunaga, Masafumi;
    • Ohgami, Tatsuhiro;
    • Onoyama, Ichiro;
    • Asanoma, Kazuo;
    • Hori, Emiko;
    • Shimokawa, Mototsugu;
    • Kato, Kiyoko
    Publication type:
    Article
    50

    Real-world clinical outcomes and prognostic factors in Japanese patients with recurrent or metastatic squamous cell carcinoma of head and neck treated with chemotherapy plus cetuximab: a prospective observation study (JROSG12-2).

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 2, p. 316, doi. 10.1007/s10147-020-01817-4
    By:
    • Yokota, Tomoya;
    • Ota, Yosuke;
    • Fujii, Hirofumi;
    • Kodaira, Takeshi;
    • Shimokawa, Mototsugu;
    • Nakashima, Torahiko;
    • Monden, Nobuya;
    • Homma, Akihiro;
    • Ueda, Shinya;
    • Akimoto, Tetsuo
    Publication type:
    Article